• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.90 -0.09 (-0.36%)
Official Closing Price Updated: 7:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
News headline image
Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts
December 18, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
December 16, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
December 15, 2025
From Adaptive Biotechnologies
Via GlobeNewswire
News headline image
Rigani Press Announces Barnes & Noble Book Signing for Dr. S. Yin Ho's Groundbreaking Book
December 12, 2025
Via PRLog
Topics Artificial Intelligence
News headline image
Pfizer Declares First-Quarter 2026 Dividend
December 12, 2025
From Pfizer Inc.
Via Business Wire
News headline image
TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer
December 10, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
December 09, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Government Relations and Policy Professional Kimberly Pinter Joins Bracewell's Policy Resolution Group in Washington, DC
December 08, 2025
Washington, D.C.--(Newsfile Corp. - December 8, 2025) - Bracewell LLP announced today that Kimberly J. Pinter has joined the firm's... 
Via Newsfile
News headline image
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
December 06, 2025
From Pfizer Inc.
Via Business Wire
News headline image
A Tale Told Through a Bird’s Eyes: Jessica Mann’s Uplift Reimagines How We See the Natural World
December 02, 2025
Via AB Newswire
Topics Bonds
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
December 02, 2025
Via Investor Brand Network
Topics Government
News headline image
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
December 01, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
December 02, 2025
From BioMedWire
Via GlobeNewswire
News headline image
BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala
December 01, 2025
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a... 
Via Newsfile
Topics Artificial Intelligence
News headline image
Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)
November 24, 2025
From Arvinas Inc.
Via GlobeNewswire
News headline image
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
November 21, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For
November 20, 2025
From BioMedWire
Via GlobeNewswire
News headline image
Pfizer Completes Acquisition of Metsera
November 13, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 12, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Global Virtual Summit Puts the Spotlight on Sickle Cell Caregivers
November 08, 2025
November 8, 2025 -- Four-Day Event Unites Families, Advocates, and Medical Experts to Prioritize Mental Wellness, Advocacy, and Legacy 
Via 24-7 Press Release
News headline image
Pfizer Responds to Delaware Chancery Court Ruling
November 05, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
November 04, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk
November 03, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement
October 31, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition
October 31, 2025
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Addresses Proposal for Metsera
October 30, 2025
From Pfizer Inc.
Via Business Wire
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
Via Investor Brand Network
News headline image
Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology
October 27, 2025
EQNX::TICKER_START (OTCQB:OTLC),(NASDAQ:IOBT),(NYSE:NVS),(NASDAQ:BCAX),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Nikki Barjon Ushers in a New Era of Branding and Legacy Building
October 23, 2025
Via Press Release Distribution Service
News headline image
Patient-Reported Outcomes from VERITAC-2 Clinical Trial Support Clinical Benefit of Vepdegestrant in Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer Previously Treated with Endocrine-Based Therapy
October 20, 2025
From Arvinas Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
39 40 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap